Menu

The Precision Medicine Revolution: CRISPR-Based Therapies

The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps for those looking to adopt the technique. 

Sep 7, 2017
The Scientist Creative Services Team

The Precision Medicine Revolution: CRISPR-Based Therapies from thescientistllc on Vimeo.

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) gene-editing technology has been hailed as a breakthrough and emerged as the new face of precision medicine. Its potential as a treatment for numerous diseases, stretching from various cancer types to neurological diseases to lethal heritable disorders, has been well documented. However, efforts are ongoing that aim to clarify the complex issues surrounding the legality and ethics of genome editing for human use. For a detailed look at the progress made toward CRISPR-mediated correction of human diseases and the continuing ethics debate, The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps for those looking to adopt the technique. Attendees will have the opportunity to interact with experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • CRISPR-generated model systems for in vivo study of a wide range of diseases
  • Therapeutic applications of genome editing and their associated societal implications

Register Now

Meet the Speakers:

Dana Carroll, PhD
Distinguished Professor, Department of Biochemistry
University of Utah School of Medicine

 

 

James Dahlman, PhD
Assistant Professor, Department of Biomedical Engineering
Georgia Institute of Technology and Emory School of Medicine

 

 




 
 

 

 

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.